Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KREKOR TOMASSIAN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1891807673
CMS profile
40750
Location
GLENDORA, CA

General Payments · PY2018–2024

$4,074.32

  • Reported across 227 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$303.36

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $303.36 14

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $641.93 49
PY2019 $550.32 37
PY2020 $613.95 32
PY2021 $827.99 46
PY2022 $570.48 22
PY2023 $566.29 27
PY2024 $303.36 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $13.46 04/08/2024 Food and Beverage Undisputed 01/23/2026 1125325852 CMS
AstraZeneca Pharmaceuticals LP $21.94 03/06/2024 Food and Beverage Undisputed 01/23/2026 1105405292 CMS
AstraZeneca Pharmaceuticals LP $22.25 06/07/2024 Food and Beverage Undisputed 01/23/2026 1105507994 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.09 04/03/2024 Food and Beverage Undisputed 01/23/2026 1086241772 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.63 09/09/2024 Food and Beverage Undisputed 01/23/2026 1086136207 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.32 04/24/2024 Food and Beverage Undisputed 01/23/2026 1118221779 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.56 06/05/2024 Food and Beverage Undisputed 01/23/2026 1118221788 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.77 10/23/2024 Food and Beverage Undisputed 01/23/2026 1118221783 CMS
Esperion Therapeutics, Inc. $25.19 10/07/2024 Food and Beverage Undisputed 01/23/2026 1129457870 CMS
Lilly USA, LLC $28.64 01/10/2024 Food and Beverage Undisputed 01/23/2026 1135109198 CMS
Novartis Pharmaceuticals Corporation $31.25 02/16/2024 Food and Beverage Undisputed 01/23/2026 1087424126 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.47 06/17/2024 Food and Beverage Undisputed 01/23/2026 1153737387 CMS
SHIELD THERAPEUTICS INC $33.72 03/13/2024 Food and Beverage Undisputed 01/23/2026 1150123833 CMS
Sumitomo Pharma America, Inc. $16.07 08/21/2024 Food and Beverage Undisputed 01/23/2026 1148928594 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.